Literature DB >> 19697132

Polycystic ovary syndrome is associated with an increased prevalence of irritable bowel syndrome.

Ruchi Mathur1, Ara Ko, Laura J Hwang, Kimberly Low, Ricardo Azziz, Mark Pimentel.   

Abstract

INTRODUCTION: Polycystic ovary syndrome (PCOS) affects 5-10% of reproductive-aged women. Irritable bowel syndrome (IBS) is a chronic intestinal disorder that affects up to 20% of adults, more often women. We evaluate if there is a relationship between these common conditions.
METHODS: Polycystic ovary syndrome and control subjects were prospectively recruited. A questionnaire was given to determine their gastrointestinal symptoms. Body mass index (BMI) and percent body fat were also calculated.
RESULTS: About 65 female subjects completed the study. Among the 36 PCOS patients, 15 subjects (42%) had IBS, compared to 3 subjects (10%) among controls (p < 0.01). Control subjects were leaner (BMI: 27.5 +/- 1.1 vs. 31.4 +/- 1.2 kg/m(2), p < 0.05) than PCOS patients. Among women with PCOS, those with IBS had a higher BMI (32.9 +/- 2.0 kg/m(2)) compared to those with PCOS but no IBS (30.3 +/- 1.6 kg/m(2)) and controls (27.5 +/- 1.1 kg/m(2); p < 0.05). This difference was true even after correcting for BMI and age (p < 0.01).
CONCLUSIONS: Women with PCOS have a higher prevalence of IBS compared to healthy controls. When IBS is present with PCOS, a higher BMI and percent body fat is seen compared to PCOS alone.

Entities:  

Mesh:

Year:  2009        PMID: 19697132     DOI: 10.1007/s10620-009-0890-5

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  38 in total

1.  Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation.

Authors:  S A Müller-Lissner; I Fumagalli; K D Bardhan; F Pace; E Pecher; B Nault; P Rüegg
Journal:  Aliment Pharmacol Ther       Date:  2001-10       Impact factor: 8.171

2.  Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature.

Authors:  Ricardo Azziz
Journal:  J Clin Endocrinol Metab       Date:  2006-01-17       Impact factor: 5.958

Review 3.  The Interstitial Cystitis Data Base Study: concepts and preliminary baseline descriptive statistics.

Authors:  L J Simon; J R Landis; D R Erickson; L M Nyberg
Journal:  Urology       Date:  1997-05       Impact factor: 2.649

4.  Obesity is associated with increased risk of gastrointestinal symptoms: a population-based study.

Authors:  Silvia Delgado-Aros; G Richard Locke; Michael Camilleri; Nicholas J Talley; Sara Fett; Alan R Zinsmeister; L Joseph Melton
Journal:  Am J Gastroenterol       Date:  2004-09       Impact factor: 10.864

5.  Interstitial cystitis; report of 223 cases (204 women and 19 men).

Authors:  J R HAND
Journal:  J Urol       Date:  1949-02       Impact factor: 7.450

6.  Impact of obesity on the risk for polycystic ovary syndrome.

Authors:  Bulent O Yildiz; Eric S Knochenhauer; Ricardo Azziz
Journal:  J Clin Endocrinol Metab       Date:  2007-10-09       Impact factor: 5.958

7.  Androgen excess in women: experience with over 1000 consecutive patients.

Authors:  R Azziz; L A Sanchez; E S Knochenhauer; C Moran; J Lazenby; K C Stephens; K Taylor; L R Boots
Journal:  J Clin Endocrinol Metab       Date:  2004-02       Impact factor: 5.958

8.  Pattern of gastrointestinal and somatic symptoms across the menstrual cycle.

Authors:  M M Heitkemper; M Jarrett
Journal:  Gastroenterology       Date:  1992-02       Impact factor: 22.682

9.  Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population.

Authors:  N J Talley; P Boyce; M Jones
Journal:  Gut       Date:  1998-05       Impact factor: 23.059

10.  The prevalence, symptom characteristics, and impact of irritable bowel syndrome in an asian urban community.

Authors:  Kok-Ann Gwee; Sharon Wee; Mee-Lian Wong; Damian J C Png
Journal:  Am J Gastroenterol       Date:  2004-05       Impact factor: 10.864

View more
  11 in total

1.  Sex difference in irritable bowel syndrome: do gonadal hormones play a role?

Authors:  Agata Mulak; Yvette Taché
Journal:  Gastroenterol Pol       Date:  2010

2.  Association between body mass index and irritable bowel syndrome in the young Japanese population: a cross-sectional study.

Authors:  Yasunori Yamamoto; Shinya Furukawa; Junichi Watanabe; Aki Kato; Katsunori Kusumoto; Teruki Miyake; Eiji Takeshita; Yoshio Ikeda; Naofumi Yamamoto; Yuka Saeki; Yoichi Hiasa
Journal:  Int J Colorectal Dis       Date:  2022-10-20       Impact factor: 2.796

Review 3.  Sex hormones in the modulation of irritable bowel syndrome.

Authors:  Agata Mulak; Yvette Taché; Muriel Larauche
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

Review 4.  Symptomatology of irritable bowel syndrome and inflammatory bowel disease during the menstrual cycle.

Authors:  Shishira Bharadwaj; Matthew D Barber; Lesley A Graff; Bo Shen
Journal:  Gastroenterol Rep (Oxf)       Date:  2015-03-18

5.  'Everything's from the inside out with PCOS': Exploring women's experiences of living with polycystic ovary syndrome and co-morbidities through Skype™ interviews.

Authors:  Sophie Williams; David Sheffield; Rebecca C Knibb
Journal:  Health Psychol Open       Date:  2015-08-31

6.  SARS-CoV-2 Viral Entry Proteins in Hyperandrogenemic Female Mice: Implications for Women with PCOS and COVID-19.

Authors:  Alexandra M Huffman; Samar Rezq; Jelina Basnet; Licy L Yanes Cardozo; Damian G Romero
Journal:  Int J Mol Sci       Date:  2021-04-25       Impact factor: 5.923

7.  Obesity Exacerbates Irritable Bowel Syndrome-Related Sleep and Psychiatric Disorders in Women With Polycystic Ovary Syndrome.

Authors:  Ping-Huei Tseng; Han-Mo Chiu; Chia-Hung Tu; Ming-Shiang Wu; Hong-Nerng Ho; Mei-Jou Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-16       Impact factor: 5.555

8.  Metformin effects on zonulin level in polycystic ovarian women.

Authors:  Manal Ibrahim; Mutaz Ahmeid
Journal:  ADMET DMPK       Date:  2022-12-09

9.  Gut microbiota alterations reveal potential gut-brain axis changes in polycystic ovary syndrome.

Authors:  Z Liang; N Di; L Li; D Yang
Journal:  J Endocrinol Invest       Date:  2021-01-02       Impact factor: 4.256

Review 10.  Sex-Bias in Irritable Bowel Syndrome: Linking Steroids to the Gut-Brain Axis.

Authors:  Sik Yu So; Tor C Savidge
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-19       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.